Wed, Aug 28, 2024
Zydus Lifesciences traded with gains after Jefferies double upgraded the counter.
More >
Fri, Jul 05, 2024
Stock Market: The domestic stock market had a weak start on Friday (July 5). There is selling pressure in banking shares. Amid the market decline, brokerage firm Motilal Oswal has made pharma sector giant Zydus Lifesciences a technical pick. Brokerage has advised buying in Zydus lifescience for 2-3 days.
Mon, Dec 18, 2023
Zydus Lifesciences blasts through the roof, hitting a 52-week high after the US FDA greenlights a Phase II trial for its Parkinson's disease drug ZYIL1! This potential blockbuster medication targets a $2 billion market, setting Zydus on fire.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
